Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Canadian Decision On Biological Names Leaves US As The Outlier
Feb 19 2019
•
By
David Wallace
The US Is Left As The Odd One Out, After Health Canada Revealed Its Biological Naming Plans • Source: Shutterstock
More from Biosimilars
More from Products